In recent years, injections with filler agents are often used for wrinkle-treatment and soft
tissue augmentation by dermatologists and plastic surgeons. Unfortunately, the ideal filler …

Background: Over the last few years, injectable soft-tissue fillers have become an integral
part of cosmetic therapy, with a wide array of products designed to fill lines and folds and …

Adsorbing small charged nanoparticles onto the outer surfaces of liposomes has become an
effective strategy to stabilize liposomes against fusion prior to “seeing” target bacteria, yet …

Introduction and hypothesis Polyacrylamide hydrogel (PAHG, Bulkamid®) is a promising
urethral bulking agent. This article presents the 2-year follow-up results of a multicenter …

Self-assembling peptides (SAPs) are rapidly gaining interest as bioinspired scaffolds for cell
culture and regenerative medicine applications. Bone Marrow Homing Peptide 1 (BMHP1) …

Skin and soft tissue infections require effective and sustained topical administration.
Platensimycin (PTM) is a natural drug lead that targets bacterial fatty acid synthases and has …

Facial rejuvenation has changed over the last decade, evolving from the rhytidectomy to an
approach that focuses on revolumization, due to a more complete understanding of the …

Natural polymers, because of their biocompatibility, availability, and physico-chemical
properties have been the materials of choice for the fabrication of injectable hydrogels for …

Lipodystrophy was first described in HIV-1-infected patients in 1998 [1–5]. The main clinical
feature is subcutaneous fat loss or lipoatrophy of the face, limbs, and buttocks [6, 7]. Patients …

HIV facial lipoatrophy (FLA) is characterized by facial volume loss. HIV FLA affects the facial
contours of the cheeks, temples, and orbits, and is associated with social stigma. Although …